Cornerstone Wealth Group LLC Purchases Shares of 20,000 Clearmind Medicine Inc. (NASDAQ:CMND)

Cornerstone Wealth Group LLC purchased a new stake in Clearmind Medicine Inc. (NASDAQ:CMND) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 20,000 shares of the company’s stock, valued at approximately $34,000. Cornerstone Wealth Group LLC owned about 1.18% of Clearmind Medicine as of its most recent filing with the Securities & Exchange Commission.

Clearmind Medicine Stock Down 5.1 %

Shares of CMND stock traded down $0.07 during mid-day trading on Friday, reaching $1.31. The stock had a trading volume of 167,072 shares, compared to its average volume of 1,748,691. The business’s fifty day moving average is $1.46 and its 200-day moving average is $1.35. Clearmind Medicine Inc. has a 1-year low of $0.92 and a 1-year high of $16.19.

Clearmind Medicine (NASDAQ:CMND) last announced its quarterly earnings data on Thursday, June 13th. The company reported ($0.28) earnings per share for the quarter.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.